Pfizer-Allergan Merger Skirts New Anti-Inversion Rules, Sticks Shareholder With The Tax Bill

• Reuven Avi-Yonah (Michigan), The Three Causes of Inversions: Reflections on Pfizer/Allergan and Notice 2015-79
• Bloomberg, Pfizer's Viagra Tax Dollars Head to Dublin as U.S. Loses Again
• Financial Times, Pfizer Set for Tax Windfall With Ireland Move
• Fortune, Why New Tax Inversion Rules Won't Stop Pfizer-Allergan Deal
• The Guardian, Pfizer's $155bn Takeover of Allergan Set to Prompt Tax Row
• Los Angeles Times, Pfizer and Allergan's $160-Billion Pharmaceutical Merger Puts New Twist on Tax-Avoiding Inversions

• Mother Jones, The Pfizer-Allergan Merger Uses a Tax Trick That Lets US Companies Stash Billions Overseas
• New York Times, Pfizer Chief Defends Merger With Allergan as Good for U.S.
• New York Times, Pfizer Deal Stokes Washington Concerns Over Tax Policy
• New York Times editorial, Pfizer’s Big Breakthrough: Global Tax Avoidance
• Reuters, Tax Policy Blowback Begins on Pfizer-Allergan Mega-Deal
• Dan Shaviro (NYU), Pfizer inversion into Allergan
• Slate, Once Again, Pfizer Is Trying to Move Overseas to Avoid U.S. Taxes
• Tax Justice Blog, Congress Must Act Now to Stop Pfizer and Other Companies from Inverting
• Time, Here’s How Much Pfizer Could Save in Taxes After Allergan Merger
• Wall Street Journal, Pfizer Inversion Puts Pressure on U.S. Lawmakers to Revamp Tax Rules
• Wall Street Journal, While Pfizer Gets a Tax Break, Many Investors Face a Hit
• Washington Post, Pfizer Gobbles Up Tax Advantages in a Turkey of a Transaction
• Washington Post, Pfizer-Allergan Merger Shows Why It’s So Hard to Stop Tax-Dodging companies
• Vox, The Pfizer-Allergan Merger Is a Huge Tax Dodge. Bernie Sanders Wants President Obama to Block It.